206 related articles for article (PubMed ID: 16359319)
1. The polysaccharide capsule of the pathogenic fungus Cryptococcus neoformans enlarges by distal growth and is rearranged during budding.
Zaragoza O; Telzak A; Bryan RA; Dadachova E; Casadevall A
Mol Microbiol; 2006 Jan; 59(1):67-83. PubMed ID: 16359319
[TBL] [Abstract][Full Text] [Related]
2. The capsular dynamics of Cryptococcus neoformans.
McFadden D; Zaragoza O; Casadevall A
Trends Microbiol; 2006 Nov; 14(11):497-505. PubMed ID: 16996739
[TBL] [Abstract][Full Text] [Related]
3. Monoclonal antibodies can affect complement deposition on the capsule of the pathogenic fungus Cryptococcus neoformans by both classical pathway activation and steric hindrance.
Zaragoza O; Casadevall A
Cell Microbiol; 2006 Dec; 8(12):1862-76. PubMed ID: 16824038
[TBL] [Abstract][Full Text] [Related]
4. The volume and hydration of the Cryptococcus neoformans polysaccharide capsule.
Maxson ME; Cook E; Casadevall A; Zaragoza O
Fungal Genet Biol; 2007 Mar; 44(3):180-6. PubMed ID: 16963294
[TBL] [Abstract][Full Text] [Related]
5. Capsule of Cryptococcus neoformans grows by enlargement of polysaccharide molecules.
Frases S; Pontes B; Nimrichter L; Viana NB; Rodrigues ML; Casadevall A
Proc Natl Acad Sci U S A; 2009 Jan; 106(4):1228-33. PubMed ID: 19164571
[TBL] [Abstract][Full Text] [Related]
6. Capsule growth in Cryptococcus neoformans is coordinated with cell cycle progression.
García-Rodas R; Cordero RJ; Trevijano-Contador N; Janbon G; Moyrand F; Casadevall A; Zaragoza O
mBio; 2014 Jun; 5(3):e00945-14. PubMed ID: 24939886
[TBL] [Abstract][Full Text] [Related]
7. Radial mass density, charge, and epitope distribution in the Cryptococcus neoformans capsule.
Maxson ME; Dadachova E; Casadevall A; Zaragoza O
Eukaryot Cell; 2007 Jan; 6(1):95-109. PubMed ID: 17114596
[TBL] [Abstract][Full Text] [Related]
8. Differential localization of complement component 3 within the capsular matrix of Cryptococcus neoformans.
Gates MA; Kozel TR
Infect Immun; 2006 Jun; 74(6):3096-106. PubMed ID: 16714537
[TBL] [Abstract][Full Text] [Related]
9. Capsular localization of the Cryptococcus neoformans polysaccharide component galactoxylomannan.
De Jesus M; Nicola AM; Rodrigues ML; Janbon G; Casadevall A
Eukaryot Cell; 2009 Jan; 8(1):96-103. PubMed ID: 18952901
[TBL] [Abstract][Full Text] [Related]
10. The efficacy of complement-mediated phagocytosis of Cryptococcus neoformans is dependent on the location of C3 in the polysaccharide capsule and involves both direct and indirect C3-mediated interactions.
Zaragoza O; Taborda CP; Casadevall A
Eur J Immunol; 2003 Jul; 33(7):1957-67. PubMed ID: 12884862
[TBL] [Abstract][Full Text] [Related]
11. Systematic capsule gene disruption reveals the central role of galactose metabolism on Cryptococcus neoformans virulence.
Moyrand F; Fontaine T; Janbon G
Mol Microbiol; 2007 May; 64(3):771-81. PubMed ID: 17462022
[TBL] [Abstract][Full Text] [Related]
12. Capsules from pathogenic and non-pathogenic Cryptococcus spp. manifest significant differences in structure and ability to protect against phagocytic cells.
Araujo Gde S; Fonseca FL; Pontes B; Torres A; Cordero RJ; Zancopé-Oliveira RM; Casadevall A; Viana NB; Nimrichter L; Rodrigues ML; Garcia ES; Souza Wd; Frases S
PLoS One; 2012; 7(1):e29561. PubMed ID: 22253734
[TBL] [Abstract][Full Text] [Related]
13. Radiological studies reveal radial differences in the architecture of the polysaccharide capsule of Cryptococcus neoformans.
Bryan RA; Zaragoza O; Zhang T; Ortiz G; Casadevall A; Dadachova E
Eukaryot Cell; 2005 Feb; 4(2):465-75. PubMed ID: 15701808
[TBL] [Abstract][Full Text] [Related]
14. Vesicular polysaccharide export in Cryptococcus neoformans is a eukaryotic solution to the problem of fungal trans-cell wall transport.
Rodrigues ML; Nimrichter L; Oliveira DL; Frases S; Miranda K; Zaragoza O; Alvarez M; Nakouzi A; Feldmesser M; Casadevall A
Eukaryot Cell; 2007 Jan; 6(1):48-59. PubMed ID: 17114598
[TBL] [Abstract][Full Text] [Related]
15. The Buoyancy of
Vij R; Cordero RJB; Casadevall A
mSphere; 2018 Nov; 3(6):. PubMed ID: 30404928
[No Abstract] [Full Text] [Related]
16. Molecular architecture of the Cryptococcus neoformans capsule.
Gates MA; Thorkildson P; Kozel TR
Mol Microbiol; 2004 Apr; 52(1):13-24. PubMed ID: 15049807
[TBL] [Abstract][Full Text] [Related]
17. Phosphorus-rich structures and capsular architecture in Cryptococcus neoformans.
Ramos CL; Gomes FM; Girard-Dias W; Almeida FP; Albuquerque PC; Kretschmer M; Kronstad JW; Frases S; de Souza W; Rodrigues ML; Miranda K
Future Microbiol; 2017 Mar; 12():227-238. PubMed ID: 28262043
[TBL] [Abstract][Full Text] [Related]
18. Cryptococcus neoformans capsular polysaccharide and exopolysaccharide fractions manifest physical, chemical, and antigenic differences.
Frases S; Nimrichter L; Viana NB; Nakouzi A; Casadevall A
Eukaryot Cell; 2008 Feb; 7(2):319-27. PubMed ID: 18156290
[TBL] [Abstract][Full Text] [Related]
19. Antibody binding to Cryptococcus neoformans impairs budding by altering capsular mechanical properties.
Cordero RJ; Pontes B; Frases S; Nakouzi AS; Nimrichter L; Rodrigues ML; Viana NB; Casadevall A
J Immunol; 2013 Jan; 190(1):317-23. PubMed ID: 23233725
[TBL] [Abstract][Full Text] [Related]
20. Cellular charge of Cryptococcus neoformans: contributions from the capsular polysaccharide, melanin, and monoclonal antibody binding.
Nosanchuk JD; Casadevall A
Infect Immun; 1997 May; 65(5):1836-41. PubMed ID: 9125569
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
